This document lists 13 types of glycogen storage disease, providing information on the deficient enzyme, incidence, symptoms, and other key details for each type. It indicates that the diseases are caused by deficiencies in enzymes involved in glycogen breakdown and synthesis, which can result in hypoglycemia, hepatomegaly, hyperlipidemia, and various muscle-related symptoms depending on the specific enzyme affected. The prognosis and potential complications, such as developmental delays, organ damage, or early death, vary significantly between the types.
This document lists 13 types of glycogen storage disease, providing information on the deficient enzyme, incidence, symptoms, and other key details for each type. It indicates that the diseases are caused by deficiencies in enzymes involved in glycogen breakdown and synthesis, which can result in hypoglycemia, hepatomegaly, hyperlipidemia, and various muscle-related symptoms depending on the specific enzyme affected. The prognosis and potential complications, such as developmental delays, organ damage, or early death, vary significantly between the types.
This document lists 13 types of glycogen storage disease, providing information on the deficient enzyme, incidence, symptoms, and other key details for each type. It indicates that the diseases are caused by deficiencies in enzymes involved in glycogen breakdown and synthesis, which can result in hypoglycemia, hepatomegaly, hyperlipidemia, and various muscle-related symptoms depending on the specific enzyme affected. The prognosis and potential complications, such as developmental delays, organ damage, or early death, vary significantly between the types.
GSD type I glucose-6-phosphatase von Gierke's disease
GSD type II acid alpha-glucosidase Pompe's disease GSD type III glycogen debranching enzyme Cori's diseaseor Forbes' disease GSD type IV glycogen branching enzyme Andersen disease GSD type V muscle glycogen phosphorylase McArdle disease GSD type VI liver glycogen phosphorylase Hers' disease GSD type VII muscle phosphofructokinase Tarui's disease GSD type IX phosphorylase kinase,PHKA2 - GSD type XI glucose transporter,GLUT2 Fanconi-Bickel syndrome GSD type XII Aldolase A Red cell aldolase deficiency GSD type XIII -enolase - GSD type 0 glycogen synthase - Incidence Hypo- Hepato- Hyperlip- glycemia? megaly? idemia? 1 in 50,000- 100,000 births Yes Yes Yes 1 in 40,000 births No Yes No 1 in 100,000 births Yes Yes Yes No Yes, also cirrhosis No 1 in 100,000[12] No No No 1 in 65,000- 85,000 births[13] Yes Yes Yes No No No Yes Yes Yes Yes Yes No ? ? ? ? ? ? Yes No No Muscle symptoms None Muscle weakness Myopathy None Exercise-induced cramps,Rhabdomyolysis None Exercise-induced muscle cramps and weakness None None Exercise intolerance,cramps Exercise intolerance,cramps Occasionalmuscle cramping Development/ prognosis Growth failure *Death by age ~2 years (infantile variant) Failure to thrive, death at age ~5 years growth retardation Delayed motor development,Growth retardation Increasing intensity ofmyalgiasover decades Other symptoms Lactic acidosis,hyperuricemia heart failure Renal failurebymyoglobinuria Haemolytic anaemia Serum CK: Episodic elevations; Reduced with rest